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Though Mycobacterium leprae is considered to be primarily a parasite of humans, there is a
long history of studies, evidence and arguments which have indicated possible non-human
sources of the agent. Thus different authors have suggested that M. leprae may be harboured
in soil,1 – 3 in water,4 on plants,5 – 7 or in various animal species including amoeba,8 insects,9,10
fish,11 – 13 primates,14 and armadillos.15,16 The question of possible extra-human sources of
M. leprae is an important one for leprosy epidemiology and control. If non-human sources
exist, their recognition may help to explain patterns of infection and disease in human
populations. Even more importantly, they would have implications for the control of the
disease, and in particular for the possibility of its ‘elimination’ or even ultimate eradication.
We consider here the nature and implications of the evidence for such extra-human sources.
There have been two different sorts of observations motivating the search for extra-
human sources of M. leprae. One is the repeated observation of clinical leprosy in
individuals with no apparent history of exposure to other known cases.17 – 20 The second is
the observation that clinical leprosy clusters in particular areas, such as near water sources,
which has led some authors to suggest that M. leprae may have an extra-human source in
such environments.21,22 Neither of these lines of argument provides a strong case for extra-
human sources of M. leprae. The long incubation period of the disease, the inability to
recall contacts and encounters years after the event, the fact that stigma leads to hiding of
cases in many societies, and the well-recognised fact that multibacillary cases can go
undetected for long periods mean that there are substantial opportunities for unrecognised,
unremembered or unacknowledged source contacts. The apparent clustering of leprosy in
particular environments may simply reflect that certain environments are associated with
certain social groups, health conditions or behaviours which predispose to M. leprae
transmission or the manifestation of leprosy disease. Or they may reflect environmental
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conditions where M. leprae is able to persist for extended periods outside the human body,
on surfaces or even in the air.
An important distinction must be made in differentiating non-human reservoirs
of M. leprae from environmental transience. Leprosy cases can shed large numbers of
bacilli into their environment through bodily secretions, or while sneezing, coughing or
talking.18,23 – 25 The fact that some leprosy bacilli may remain viable in certain cell-free
environments for periods of hours, days or even weeks,26 – 28 does not mean that they persist as
an infectious reservoir. The distinction here is whether the bacilli can replicate. Given what is
now known of the abbreviated genome of M. leprae, it is most unlikely that leprosy bacilli can
replicate in any extra-cellular environment.29 Though the literature contains several claims
of culture of M. leprae in cell-free media,30,31 no such claim ever has been substantiated,
and there is now a strong a priori argument against such a possibility. Though one must be
open minded about the possibility that M. leprae in water could reflect their association
with protozoa, or with aquatic invertebrate hosts, as has been suggested for M. ulcerans,32
the notion of free-living M. leprae persisting in the environment is implausible biologically.
It is possible that M. leprae could persist within other vertebrates. However, investigators
seeking to propagate M. leprae in the laboratory have examined a long list of experimental
hosts and found only a very limited host range.33 – 36 Some species of primates appear to be
marginally susceptible to experimental infection, and a few of them have developed
spontaneous leprosy while in captivity.37,38 However, infection among free-ranging primates
has not been reported. M. leprae’s predilection for cool body temperatures was recognised
soon after Hansen described the bacillus, and as early as 1911 Couret suggested that fish
might be suitable hosts for propagating leprosy bacilli.39 However, even with the increased
use of fish as experimental laboratory animals seen in recent years, there have been no
credible reports of successful infection and replication of M. leprae in fish. Aside from the
primate infections mentioned above, the only two non-human environments in which
M. leprae are known reliably to replicate are the footpad of the mouse (Mus musculus), and
the nine-banded armadillo (Dasypus novemcinctus).
The ability of the mouse footpad to support M. leprae, discovered by Shepard in 1960,40
was a crucially important discovery in the history of leprosy research, but there has never
been any evidence that this serves as a source of bacilli outside the artificial confines of the
laboratory. Indeed, the conventional mouse is relatively resistant to M. leprae and will kill
and eliminate the bacilli after infection in the foot pad reaches a certain threshold.41
The armadillo story is different.
M. leprae in armadillos:
Although the original demonstration that M. leprae can grow in the nine-banded
armadillo was carried out in a laboratory,42 there have now been repeated demonstrations that
M. leprae is harboured in wild armadillos over a wide area of North America.43 It is important
to appreciate the nature and strength of this evidence. It includes: typical pathology,44 skin
test reactivity,45 genomic sequence analysis,46 M. leprae-specific serology16 and PCR,47
isolation and passage of bacilli in other animals, and epidemiological associations of
armadillo contact with human cases.19,48 – 50 Given the magnitude and variety of this
evidence, there is no doubt that M. leprae persists among wild armadillos in the southern
USA, and it may extend to contiguous armadillo populations in parts of Mexico. However,
there is only a single report of M. leprae among armadillos in Mexico,51 and further evidence
is needed to clarify the southern range limits of sylvan leprosy. Whether M. leprae exists
among armadillos elsewhere in the Americas remains an unresolved but important question.
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Though negative reports from surveys are seldom published, none of the South American
groups recruiting armadillos for laboratory studies in the 1970s reported evidence of naturally
occurring M. leprae infection among the animals they collected in Brazil,52 French Guiana53
or Argentina,54 and surveys on different species of armadillos in Colombia55 and Paraguay56
also found no (0/536) evidence for the infection. South American armadillos were thus
considered to be free of M. leprae infection, or at least less involved than their North
American counterparts. The only exception to this view were reports of a naturally occurring
systemic mycobacteriosis, believed to be caused by M. leprae, affecting a total of nine of the
132 armadillos examined at a laboratory in northern Argentina over a 22 year period from
1979 to 2001.57 – 59 Over the past few years, however, two studies have been published
reporting PCR evidence for M. leprae infection in five out of 14 armadillos in Espirito Santos,
Brazil,60 and in nine out of 22 armadillos collected in the Andes region of Colombia.61
Neither of these studies included other diagnostic tests to corroborate the PCR observations.
Subsequent serological screening was performed in Brazil, but those later results were not
correlated with the PCR data,62,63 and separate histopathological studies were found to be
negative.64 None of these observations of possible M. leprae infections among South
American armadillos have been confirmed by other laboratories, and a recent survey in Sao
Paulo, Brazil found no evidence for M. leprae infection among the 44 armadillos and several
other wildlife species they examined.65 Thus it remains unclear whether these previous
findings indicate a new paradigm or are somehow erroneous.
METHODOLOGICAL ISSUES
The convincing demonstration of M. leprae, or M. leprae infection, is rarely easy. This is
even true in the context of diagnosing an appreciable proportion of human cases in leprosy-
endemic regions. The presence of classical clinical lesions plays a major role in diagnosing
human leprosy, sometimes supported by bacteriological (slit skin smear) or histopathological
evidence. PCR is sometimes (rarely) used as a diagnostic aid when atypical clinical or
histopathologic features obscure a clear diagnosis, but PCR itself is not thought to be highly
informative when acid-fast bacilli are not detectable by light microscopy in biopsies.66
Though several authors have reported PCR evidence for M. leprae in nasal smears of
clinically healthy individuals in leprosy endemic communities, the validity of the evidence
for M. leprae, and risks of false positivity are a major concern with these studies.67,68
The convincing demonstration of M. leprae in non-human material raises additional
difficulties. Like humans, armadillos exhibit the full immunological and histopathological
spectrum of leprosy, and many of the same laboratory methods used to help diagnose leprosy
in humans can be used with armadillos. However, because the disease manifests systemically
in armadillos, with few skin lesions, evidence for the infection is found earlier and more
frequently with examination of reticuloendothelial (RES) tissues such as lymph nodes.47,69
If total necropsy is not possible, PGL1 specific serology, which becomes positive after
bacillary load in the RES attains a certain threshold, is the second most sensitive tool.70,71
Though dissemination of M. leprae to skin or ear tissues occurs relatively late in armadillo
infections and is detectable far less frequently (5–10 fold) than the other methods,72,73
histopathological demonstration of M. leprae in dermal nerves remains pathognominic for
leprosy in both humans and armadillos.74 Given the well known problems of contamination
and false positive reactions with PCR or serology, investigators should include a combination
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of the available diagnostic techniques to confirm a diagnosis of M. leprae infection and
corroborate their findings.75
Neural involvement with M. leprae, the gold standard for diagnosing leprosy, has been
shown only among humans, armadillos and primates. It is not seen in rodents, guinea pigs or
other laboratory animals. Individuals examining hosts with atypical pathology must adjust
their techniques accordingly and incorporate different combinations of methods.
Investigators seeking to elaborate new and novel findings bear a substantial burden of
proof to demonstrate the validity of new paradigms. In the case of M. leprae, this requires
high standards of scientific rigour:
. Using the full array of diagnostic tests available: PCR, serology, histopathology, isolation
of bacilli in animals; and critically correlating those results in a biologically plausible
manner.
. With reference to PCR, one must appreciate that our knowledge of microbial and other
genomes in nature is still quite limited, and there are millions of organisms that are yet to
be described. PCR studies thus should be conducted with primers that amplify multiple
segments of the chromosome and the resulting amplicons should be sequenced to confirm
the desired product.
. Appropriate positive and negative controls should be included for the obvious pitfalls of
laboratory or skin surface contamination. Ideally these should be blind coded so that their
true status is unknown to the laboratory staff involved.
. Case control studies investigating contact with armadillos should control for obvious
confounders including urban rural and socio-economic factors, in addition to age, sex,
BCG status etc.
. Observations should be confirmed, preferably independently. This should be doable
relatively easily, by a variety of methods (including simple histopathology), given the
extraordinarily high prevalences reported recently from Brazilian and Colombian
armadillos.60,61
Discussion
A critical survey of the literature on ‘environmental’ sources of M. leprae, leads us to
conclude that the only convincing evidence for a non-human reservoir is that pertaining to
nine-banded armadillos in the southern USA. The reports to date of evidence for M. leprae
in armadillo populations elsewhere are intriguing, and potentially important, but require
rigorous confirmation.
The issue of the range of M. leprae infection in armadillos is important for our
understanding of leprosy. It is generally agreed that leprosy did not exist in the Americas
during pre-Colombian times, and thus M. leprae must have been introduced into armadillos
from infected humans some time in the last 500 years. Armadillos expanded their range into
the USA only in the 1880s, and as a result of several separate introductions of the animals
from Texas and Louisiana in the west (where M. leprae infection in now widespread) into
Florida and other eastern states (where armadillos are considered to be free of M. leprae), two
separate populations were formed.76 These western and eastern populations have merged in
recent decades, but there is much evidence that M. leprae infection is not uniformly
distributed over the animal’s range in the USA. Rather, it is found most commonly among
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animals in low lying and coastal marsh areas of the western range.43 A recent report of
M. leprae infection among armadillos in Alabama suggests that the infection can spread in the
region.77 However, the apparent continued absence of M. leprae among armadillos in central
Texas and Oklahoma, parts of Mississippi, as well as Georgia and Florida43 provides
evidence that spread of the infection is neither rapid nor certain, and it would be erroneous to
presume that armadillos in all locations are reservoir hosts of M. leprae.
If M. leprae does persist in armadillos elsewhere in the Americas it will be important to
map the distribution of the infections and to carry out appropriate molecular epidemiological
studies to see if the bacilli reflect more than one introduction from human sources. This would
inform us of the efficiency (determinants and rapidity) of spread within the armadillo
populations. This will in turn have important public health implications in terms of guiding
leprosy diagnostic suspicion, and leprosy control, throughout the Americas. For all such
reasons rigorous studies of M. leprae in armadillos are of high priority.
In conclusion we note that most of the recent claims of extra-human sources of M. leprae
have been based upon PCR evidence. It is important for researchers, journal reviewers,
journal editors, and those reading the literature, to be aware of the problems with such
evidence. The issues at stake are important – we must all insist upon high standards of
evidence.
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